Z-TAXEL 260MG INJECTION
| Brand Name | Z-Taxel |
|---|---|
| Dosage Form | Injection |
| Strength | 260 mg |
| Active Ingredient | Paclitaxel |
| Route of Administration | Intravenous (IV) |
| Therapeutic Class | Anticancer/Antineoplastic |
| Prescription Required | Yes |
| Storage | Store below 25°C and protect from light |
| Manufacturer | As per the pack details |
Z-TAXEL 260MG INJECTION
Z-Taxel 260mg Injection contains paclitaxel, a widely used anticancer chemotherapy medicine indicated for the treatment of breast cancer, ovarian cancer, and non-small cell lung cancer (NSCLC). It is a trusted oncology drug commonly included in combination chemotherapy regimens for effective cancer management.
Paclitaxel works by disrupting the normal function of microtubules within cancer cells, thereby preventing cell division and stopping tumor growth. By inhibiting uncontrolled cancer cell proliferation, Z-Taxel Injection helps slow disease progression and enhances treatment outcomes in various solid tumors.
Z-Taxel 260 mg Injection is administered intravenously in hospital or clinical oncology settings under strict medical supervision. As a prescription-only chemotherapy injection, it is used according to an oncologist’s guidance to ensure safe dosing, proper monitoring, and optimal therapeutic benefit during cancer treatment.
Product Features
- Contains Paclitaxel, a proven anticancer agent
- Used in breast, lung, and ovarian cancer treatment
- Helps stop cancer cell division and growth
- Administered via intravenous infusion
- Prescription-only oncology medication
- Suitable for hospital and clinical oncology use
How It Helps
- Stops cancer cell division by stabilizing microtubules
- Slows tumor growth and spread in breast, ovarian, and lung cancers
- Enhances treatment effectiveness in combination chemotherapy regimens
- Improves disease control under supervised oncology care

Reviews
There are no reviews yet.